Soluble cMet levels in urine are a significant prognostic biomarker for diabetic nephropathy
Abstract Hepatocyte growth factor and its receptor cMet activate biological pathways necessary for repair and regeneration following kidney injury. Here, we evaluated the clinical role of urinary cMet as a prognostic biomarker in diabetic nephropathy (DN). A total of 218 patients with DN were enroll...
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2018-08-01
|
| Series: | Scientific Reports |
| Online Access: | https://doi.org/10.1038/s41598-018-31121-1 |